The actMty of dipeptidyl peptidase IV (EC 3.4.14.5) in human sera from normal controls and osteoporotic patients was assayed with GIy-Pro-4-methylcoumaryl-7-amide (Gly-Pro-MCA) as substrate, at pH 8.7. The mean normal value for the activity in serum of 120 healthy subjects (ages 20-86 y) was 54.0 (SE 0.9, range 34.3-81.6) U/L at 37#{176}C and differed slightly but significantly between the younger group (<50 y old) and those older than 50 y. Values for the younger men were slightly but significantly higher than for the older men. Overall, however, the enzyme activities in serum were above normal in patients with osteoporosis. In contrast, the activity of post-proline cleaving enzyme (PPCE) was not increased in serum from patients with osteoporosis, as determined with succinyl-Gly-Pro-4-methylcoumaryl-7-amide (Suc-Gly-Pro-MCA) as substrate. These results suggest that high activities of dipeptidyl peptidase IV in serum of patients with osteoporosis are probably related to its severity.
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Pro-MCA), had similar substrate activity to Gly-Pro pnitroanilide (5) . The physiological role of DAP N is not clear. One probable function is hydrolysis of peptides derived from collagen, which contains repeated Gly-Pro sequences. The other probable function is hydrolysis of substance P in the brain (6) . We had previously reported the activity of DAP N in normal human serum with X-Pro p-nitroanilides as substrates and demonstrated that the activity of the enzyme was abnormally increased in patients with hepatobiliary diseases, and decreased in patients with various solid and blood cancers (7) (8) (9) , and in collagen diseases such as rheumatoid arthritis and lupus erythematosus (10). Post-proline cleaving enzyme (PPCE, prolyl endopeptidase, EC 3.4.21.26), being also a serine peptidase, cleaves -X-Pro-Yto yield -X-Pro and Y. PPCE is capable of degrading many neuropeptides, such as substance P, angiotensin U, bradykimm, and neurotensin (11). Suc-Gly-Pro-MCA is one of the most sensitive substrates for PPCE (12). Here, we report DAP N activities, with Gly.Pro-MCA as substrate, and PPCE activities, with Suc-Gly-Pro-MCA as substrate, in human sera from osteoporotic patients, whose collagenolytic activity in bone is assumed to be greater than that for normal controls.
Materials and Methods
Blood was sampled by venipuncture. After clotting, the serumwas separatedby centrifuging at 700 x g for 15 mm. The ages and sexes of the 120 normal subjects and 30 subjects with osteoporosis are shown in Table 1 thyroidism, androgen deficiency) were excluded. The control population of older women was closely agematched to the osteoporotic population. In osteoporotic subjects, DAP N activities were compared with the grade of severity of osteoporosis according to the Pogrund index.
Gly-Pro-MCA, synthesized as described previously (1), was used to measure DAP-N activity by fluorometry of the 7-amino-4-methylcoumarin (AMC) liberated from the substrate (1) . DAP-N activity was measured as described previously (4), except that we changed the pH of the incubation to the optimal pH 8.7 in glycinefNaOH buffer, instead of pH 7.0 in PPCE activity with Suc-Gly-Pro-MCA as substrate (synthesized at the Peptide Institute) was also assayed by the fluorometric measurement of AMC liberated from the substrate (6).
The reaction mixture (total volume, 0.1 mL) contained 25 pL of sodium phosphate buffer (pH 6.8, 0.2 mol/L, containing 1 mmol of EDTA per liter), 50 zL of 2 mmol/L Suc-GlyPro-MCA, and 25 zL of human serum. Instead of serum, the blank and standard tubes respectively contained 25 1zL of water and 15 iL of water plus 10 p.L (1.00 nmol) of the 100 imo1/L AMC standard.
The control tube contained no serum. The rest of the procedure was as described for DAP N except that incubation was for 10 rain, and the AMC liberated, UIL in serum (37 #{176}C), was calculated as:
Alkaline phosphatase (15), Ca (16), and P (17) in serum were measured by conventional procedures.
Results
Measurements of enzyme reaction products varied linearly with duration of incubation (for at least 2 h at 37 #{176}C) and with the volume of serum (5-60 giL). Mean DAP N activity, as measured with Gly-Pro-MCA as substrate, in 120 normal human sera was 54.0 (SE 0.9) UIL (Table 1) . The mean values for control subjects younger than 50 years were slightly but significantly (P <0.05) higher than those for male control subjects older than 50 y, but this was not the case for the women.
The mean value for activities for 30 women with osteoporosis was 70.7 (SE 1.8, range 53.4-96.0) U/L, significantly (P <0.001) higher than in the older group of healthy women. Moreover, the activity was increased in parallel with the severity of the osteoporosis (Figure 1) . Mean PPCE activity in serum from women with osteoporosis was not significantly different from that from the older female control group: 4.04 (SE 0.10, range 2.37-5.17) 
Discussion
In our previous reports, the activity of DAP N in serum with Gly-Pro f3-naphthylamide as substrate was found to be a diagnostic index in some diseases (8, 9) .
In the present study, DAP IV activity as measured in normal human serum with Gly-Pro-MCA as substrate was -50 U/L, and individual variations were small. This result was similar to our previous report, although another substrate was used in that study.
The enzyme activities differed slightly but significantly with age between the younger group (<50 y old) and the older group (>50 y old). Men, especially the younger ones, had significantly higher activities than did older men. Hino et al. (7) reported age-related changes of DAP IV activities with Gly-Pro 3-naphthylamide as substrate in normal human sera; values for the younger group (<40 y old) of men were higher than those >40 y old, but values for older women were higher than those for younger ones. We observed a similar change for men, but not for women. The reason may be too small (n = 11 to 24) numbers of subjects in their (7) study. The serum enzyme activity was found to be increased in women with osteoporosis. Most women with osteoporosis have high bone turnover, or at least a higher rate of resorption than of formation of bone (14) . A physiological significance of DAP IV is considered to be implicated in the degradation of peptides derived from collagen, because the enzyme preferentially hydrolyzes the N-terminal glycylproline sequence (4). Therefore, our results are interpreted as being an indication of increased collagen breakdown in the bone of patients with osteoporosis. In thct, the degree of increase in serum DAP N activity paralleled the severity of osteoporosis. As a result of increased collagen breakdown, hyper-resorption of bone may occur in osteoporosis.The high DAP N activity in sera from women with osteoporosis is probably related to the process of hyper-resorption of bone in osteoporosis.
